Brief: ReShape Lifesciences Reports First Quarter 2023 Financial Results
May 15 (Reuters) - ReShape Lifesciences Inc RSLS.O :
* RESHAPE LIFESCIENCES® REPORTS FIRST QUARTER ENDED MARCH
31, 2023
FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
* RESHAPE LIFESCIENCES INC - CASH AND CASH EQUIVALENTS AS OF
MARCH
31, 2023, WERE $9.1 MILLION
* RESHAPE LIFESCIENCES INC - BELIEVES CASH AND CASH
EQUIVALENTS AS
OF MARCH 31, 2023 SUFFICIENT TO FUND CURRENT OPERATIONS INTO
2024
Source text for Eikon: ID:nGNX9YRmpD
Further company coverage: RSLS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vyome Holdings
See all newsBrief: Vyome - Appoints Jerry Leonard As CFO On August 27, 2026 - SEC Filing
Biopharma firm Vyome Holdings posts Q2 net loss
Vyome Holdings Inc reports results for the quarter ended June 30 - Earnings Summary
Vyome Holdings Inc expected to post a loss of 19 cents a share - Earnings Preview
Brief: Vyome Strikes Deal With Impetis Biosciences, Opening A ~$57B Market Opportunity